Publications by authors named "N C Goodman"

Harvesting of stormwater and injecting it into aquifers for storage and recovery during high water demand periods is a promising technology for augmenting conventional water reserves. However, little has been known on how stormwater impacts the biofouling of water distribution infrastructure. This study evaluated the effect on harvested and limestone aquifer treated stormwater on biofilm formation in a pilot distribution pipe network compared to an identical drinking water pipe rig.

View Article and Find Full Text PDF

We summarize the recent progress made by probabilistic programming as a unifying formalism for the probabilistic, symbolic, and data-driven aspects of human cognition. We highlight differences with meta-learning in flexibility, statistical assumptions and inferences about cogniton. We suggest that the meta-learning approach could be further strengthened by considering Connectionist Bayesian approaches, rather than exclusively one or the other.

View Article and Find Full Text PDF

Background: Smoking is a leading cause of premature mortality and morbidity globally. The pollutants generated from smoke are not only harmful to smokers, but also to those exposed to secondhand smoke. As a result of increasingly restrictive indoor smoke-free policies in many countries, there is a tendency for tobacco smoking to move outdoors into partially enclosed settings in hospitality venues.

View Article and Find Full Text PDF

Real-world communication frequently requires language producers to address more than one comprehender at once, yet most psycholinguistic research focuses on one-on-one communication. As the audience size grows, interlocutors face new challenges that do not arise in dyads. They must consider multiple perspectives and weigh multiple sources of feedback to build shared understanding.

View Article and Find Full Text PDF

Increasing numbers of cell and gene therapies (CGTs) are emerging to treat and cure pediatric diseases. However, small market sizes limit the potential return on investment within the traditional biopharmaceutical drug development model, leading to a market failure. In this Perspective, we discuss major factors contributing to this failure, including high manufacturing costs, regulatory challenges, and licensing practices that do not incorporate pediatric development milestones, as well as potential solutions.

View Article and Find Full Text PDF